Peregrine Capital Management LLC Cytokinetics Inc Transaction History

Peregrine Capital Management LLC

$3.18 Billion
Q4 2024

A detailed history of Peregrine Capital Management LLC transactions in Cytokinetics Inc stock. As of the latest transaction made, Peregrine Capital Management LLC holds 150,343 shares of CYTK stock, worth $6.57 Million. This represents 0.22% of its overall portfolio holdings.

Number of Shares

150,343

Previous 140,911 6.69%

Holding current value

$6.57 Million

Previous $7.44 Million 4.95%

% of portfolio

0.22%

Previous 0.23%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 31, 2025	BUY	$46.36 - $58.62 $437,267 - $552,903	9,432 Added 6.69%	150,343 $7.07 Million
Q3 2024 Oct 24, 2024	BUY	$51.22 - $60.16 $15,878 - $18,649	310 Added 0.22%	140,911 $7.44 Million
Q2 2024 Jul 29, 2024	BUY	$47.86 - $75.05 $679,994 - $1.07 Million	14,208 Added 11.24%	140,601 $7.62 Million
Q1 2024 Apr 26, 2024	SELL	$63.75 - $108.06 $326,463 - $553,375	-5,121 Reduced 3.89%	126,393 $8.86 Million
Q4 2023 Jan 26, 2024	SELL	$26.88 - $83.49 $1.97 Million - $6.11 Million	-73,150 Reduced 35.74%	131,514 $11 Million
Q3 2023 Oct 19, 2023	BUY	$29.46 - $36.61 $705,154 - $876,296	23,936 Added 13.24%	204,664 $6.03 Million
Q2 2023 Jul 26, 2023	SELL	$32.62 - $40.75 $609,602 - $761,536	-18,688 Reduced 9.37%	180,728 $5.9 Million
Q1 2023 Apr 26, 2023	BUY	$33.36 - $45.71 $1.31 Million - $1.8 Million	39,273 Added 24.52%	199,416 $7.02 Million
Q4 2022 Jan 10, 2023	BUY	$35.77 - $51.11 $404,522 - $578,002	11,309 Added 7.6%	160,143 $7.34 Million
Q3 2022 Oct 26, 2022	SELL	$38.54 - $54.52 $988,897 - $1.4 Million	-25,659 Reduced 14.7%	148,834 $7.21 Million
Q2 2022 Jul 20, 2022	SELL	$33.93 - $48.92 $1.53 Million - $2.2 Million	-45,047 Reduced 20.52%	174,493 $6.86 Million
Q1 2022 Apr 27, 2022	BUY	$29.74 - $46.0 $93,978 - $145,360	3,160 Added 1.46%	219,540 $8.08 Million
Q4 2021 Jan 31, 2022	SELL	$34.35 - $46.38 $2.48 Million - $3.34 Million	-72,116 Reduced 25.0%	216,380 $9.86 Million
Q3 2021 Nov 02, 2021	SELL	$18.54 - $35.74 $2.52 Million - $4.85 Million	-135,679 Reduced 31.99%	288,496 $10.3 Million
Q2 2021 Aug 03, 2021	SELL	$19.79 - $26.99 $442,880 - $604,009	-22,379 Reduced 5.01%	424,175 $8.39 Million
Q1 2021 May 11, 2021	SELL	$18.57 - $25.68 $2.03 Million - $2.8 Million	-109,130 Reduced 19.64%	446,554 $10.4 Million
Q4 2020 Jan 19, 2021	BUY	$15.26 - $28.61 $8.48 Million - $15.9 Million	555,684 New	555,684 $11.5 Million

Others Institutions Holding CYTK

# of Institutions

397

Shares Held

122M

Call Options Held

3.46M

Put Options Held

1.86M

View Full List

About CYTOKINETICS INC

Ticker CYTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,144,096
Market Cap $4.11B
Description
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...

More about CYTK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Peregrine Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Peregrine Capital Management LLC with notifications on news.

Account

Peregrine Capital Management LLC Cytokinetics Inc Transaction History